The biological vaccine sector opened high, with North China Pharmaceuticals and Laimei Pharmaceuticals both rising and stopping, while Haixin Co., Ltd., Cansino, Zhongheng Group, Dongfulong, and Kangtai Biotech followed suit. In terms of related ETFs, the biomedical ETF Huitianfu had a turnover of 412,900 yuan. According to the news, the latest public data from the US Centers for Disease Control and Prevention shows that as of October 8, 2026, the number of confirmed cases of measles in the US this year has climbed to 4,080, which has already surpassed the total number of 2,289 cases in 2025, setting a new annual high for more than 30 years since 1991.

The biological vaccine sector opened high, with North China Pharmaceuticals and Laimei Pharmaceuticals both rising and stopping, while Haixin Co., Ltd., Cansino, Zhongheng Group, Dongfulong, and Kangtai Biotech followed suit. In terms of related ETFs, the biomedical ETF Huitianfu had a turnover of 412,900 yuan. According to the news, the latest public data from the US Centers for Disease Control and Prevention shows that as of October 8, 2026, the number of confirmed cases of measles in the US this year has climbed to 4,080, which has already surpassed the total number of 2,289 cases in 2025, setting a new annual high for more than 30 years since 1991.